ID

36975

Beschreibung

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb); ODM derived from: https://clinicaltrials.gov/show/NCT02032836

Link

https://clinicaltrials.gov/show/NCT02032836

Stichworte

Versionen (2)
  1. 25.06.19 25.06.19 -
  2. 17.09.21 17.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

25. Juni 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Pulmonary Arterial Hypertension NCT02032836

Englisch

Eligibility Pulmonary Arterial Hypertension NCT02032836

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female aged ≥ 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
current diagnosis of pulmonary hypertension (updated dana point classification 1).
Beschreibung

Pulmonary Hypertension Classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C0008902
current inhalative therapy with 5 µg iloprost using the i-neb nebulizer
Beschreibung

Inhalation Therapy Iloprost Dose | Use of Nebulizer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021459
UMLS CUI [1,2]
C0079594
UMLS CUI [1,3]
C0178602
UMLS CUI [2,1]
C1524063
UMLS CUI [2,2]
C0027524
who functional class iii at the time of the patient's commencement of inhalative therapy with iloprost
Beschreibung

World Health Organization Class Functional

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0043237
UMLS CUI [1,2]
C0456387
UMLS CUI [1,3]
C0205245
hemodynamic diagnosis of pulmonary arterial hypertension(pah) showing mean pulmonary arterial pressure (mpap) > 25 mmhg, pulmonary capillary wedge pressure (pcwp) or left ventricular end diastolic pressure (lvedp) < 15 mmhg and pulmonary vascular resistance (pvr) > 320 dyn•s•cm-5
Beschreibung

Pulmonary arterial hypertension | Mean pulmonary arterial pressure | Pulmonary Capillary Wedge Pressure | Left ventricular end-diastolic pressure level | Pulmonary Vascular Resistance

Datentyp

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2]
C3854605
UMLS CUI [3]
C0086879
UMLS CUI [4]
C0456190
UMLS CUI [5]
C0456261
if non-specific types of chronic treatment for pah are being administered: stable dosage of these for at least the 4 weeks up to screening
Beschreibung

Therapeutic procedure chronic Pulmonary arterial hypertension | Dose Stable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205191
UMLS CUI [1,3]
C2973725
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0205360
if pah-specific drug treatments (such as endothelin receptor antagonist (era) or phosphodiesterase-5 (pde5) inhibitors) are being administered: stable dosage of these for at least the 3 months up to screening.
Beschreibung

Pharmacotherapy Pulmonary arterial hypertension Specific | Endothelin receptor antagonist Dose Stable | Phosphodiesterase 5 inhibitor Dose Stable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C2973725
UMLS CUI [1,3]
C0205369
UMLS CUI [2,1]
C1134681
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C1318700
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pah related to any other etiology, especially to pulmonary veno-occlusive disease (pvod)
Beschreibung

Pulmonary arterial hypertension Relationship Etiology | Etiology Pulmonary Veno-Occlusive Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2973725
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0015127
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0034091
clinically relevant obstructive lung disease
Beschreibung

Lung Diseases, Obstructive

Datentyp

boolean

Alias
UMLS CUI [1]
C0600260
evidence of thromboembolic disease (probable pulmonary embolism) within 3 years before screening
Beschreibung

Thromboembolism | Pulmonary Embolism Probable

Datentyp

boolean

Alias
UMLS CUI [1]
C0040038
UMLS CUI [2,1]
C0034065
UMLS CUI [2,2]
C0033204
cerebrovascular events within 3 months before screening
Beschreibung

Event Cerebrovascular

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C1880018
atrial septostomy within the 6 months before screening
Beschreibung

Atrial septostomy

Datentyp

boolean

Alias
UMLS CUI [1]
C0397233
severe arrhythmia, or severe coronary heart disease or unstable angina, or myocardial infarction within 6 months before screening, or congenital or acquired valvular defects with clinically relevant myocardial function disorders unrelated to pah
Beschreibung

Cardiac Arrhythmia Severe | Coronary heart disease Severe | Angina, Unstable | Myocardial Infarction | Valvular defects Congenital | Valvular defects Acquired | Cardiomyopathy Independent of Pulmonary arterial hypertension

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0010068
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0002965
UMLS CUI [4]
C0027051
UMLS CUI [5,1]
C2748945
UMLS CUI [5,2]
C1744681
UMLS CUI [6,1]
C2748945
UMLS CUI [6,2]
C0439661
UMLS CUI [7,1]
C0878544
UMLS CUI [7,2]
C0332291
UMLS CUI [7,3]
C2973725
systolic blood pressure < 85 mm hg, or uncontrolled systemic hypertension (systolic bp > 160 mmhg or diastolic bp > 100 mmhg)
Beschreibung

Systolic Pressure | Hypertensive disease Uncontrolled | Diastolic blood pressure

Datentyp

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2,1]
C0020538
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0428883
hepatic impairment (child pugh b, c) or chronic renal insufficiency (creatinine > 2.5 mg/dl) and /or requirement of dialysis
Beschreibung

Hepatic impairment Child-Pugh Classification | Chronic Kidney Insufficiency | Creatinine measurement, serum | Requirement Dialysis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0948807
UMLS CUI [1,2]
C2347612
UMLS CUI [2]
C0403447
UMLS CUI [3]
C0201976
UMLS CUI [4,1]
C1514873
UMLS CUI [4,2]
C0011946
clinically relevant bleedings disorders or conditions with increased risk for hemorrhages (active ulcers, trauma etc.)
Beschreibung

Blood Coagulation Disorders | High risk of Hemorrhage | Ulcer | Trauma

Datentyp

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2,1]
C0332167
UMLS CUI [2,2]
C0019080
UMLS CUI [3]
C0041582
UMLS CUI [4]
C3714660
addition or dose change of pah specific drug treatments such as era or pde5 inhibitors within 3 months before screening, or addition or dose change of non-specific treatments for pah such as calcium channel blockers, nitrates, digitalis, diuretics within 4 weeks before screening, or any kind of prostanoid other than those mentioned in inclusion criteria within less than 5 half-lives before treatment
Beschreibung

Pharmacotherapy Pulmonary arterial hypertension Specific | Pharmacotherapy Additional | Medication dose changed | Endothelin receptor antagonist | Phosphodiesterase 5 inhibitor | Therapeutic procedure Additional Pulmonary arterial hypertension | Calcium Channel Blockers | Nitrates | Digitalis preparation | Diuretics | Prostaglandins

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C2973725
UMLS CUI [1,3]
C0205369
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C1524062
UMLS CUI [3]
C1608430
UMLS CUI [4]
C1134681
UMLS CUI [5]
C1318700
UMLS CUI [6,1]
C0087111
UMLS CUI [6,2]
C1524062
UMLS CUI [6,3]
C2973725
UMLS CUI [7]
C0006684
UMLS CUI [8]
C0028125
UMLS CUI [9]
C0304520
UMLS CUI [10]
C0012798
UMLS CUI [11]
C0033554
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Pulmonary Arterial Hypertension NCT02032836

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female aged ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Pulmonary Hypertension Classification
Item
current diagnosis of pulmonary hypertension (updated dana point classification 1).
boolean
C0020542 (UMLS CUI [1,1])
C0008902 (UMLS CUI [1,2])
Inhalation Therapy Iloprost Dose | Use of Nebulizer
Item
current inhalative therapy with 5 µg iloprost using the i-neb nebulizer
boolean
C0021459 (UMLS CUI [1,1])
C0079594 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C1524063 (UMLS CUI [2,1])
C0027524 (UMLS CUI [2,2])
World Health Organization Class Functional
Item
who functional class iii at the time of the patient's commencement of inhalative therapy with iloprost
boolean
C0043237 (UMLS CUI [1,1])
C0456387 (UMLS CUI [1,2])
C0205245 (UMLS CUI [1,3])
Pulmonary arterial hypertension | Mean pulmonary arterial pressure | Pulmonary Capillary Wedge Pressure | Left ventricular end-diastolic pressure level | Pulmonary Vascular Resistance
Item
hemodynamic diagnosis of pulmonary arterial hypertension(pah) showing mean pulmonary arterial pressure (mpap) > 25 mmhg, pulmonary capillary wedge pressure (pcwp) or left ventricular end diastolic pressure (lvedp) < 15 mmhg and pulmonary vascular resistance (pvr) > 320 dyn•s•cm-5
boolean
C2973725 (UMLS CUI [1])
C3854605 (UMLS CUI [2])
C0086879 (UMLS CUI [3])
C0456190 (UMLS CUI [4])
C0456261 (UMLS CUI [5])
Therapeutic procedure chronic Pulmonary arterial hypertension | Dose Stable
Item
if non-specific types of chronic treatment for pah are being administered: stable dosage of these for at least the 4 weeks up to screening
boolean
C0087111 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C2973725 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Pharmacotherapy Pulmonary arterial hypertension Specific | Endothelin receptor antagonist Dose Stable | Phosphodiesterase 5 inhibitor Dose Stable
Item
if pah-specific drug treatments (such as endothelin receptor antagonist (era) or phosphodiesterase-5 (pde5) inhibitors) are being administered: stable dosage of these for at least the 3 months up to screening.
boolean
C0013216 (UMLS CUI [1,1])
C2973725 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C1134681 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C1318700 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Pulmonary arterial hypertension Relationship Etiology | Etiology Pulmonary Veno-Occlusive Disease
Item
pah related to any other etiology, especially to pulmonary veno-occlusive disease (pvod)
boolean
C2973725 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2,1])
C0034091 (UMLS CUI [2,2])
Lung Diseases, Obstructive
Item
clinically relevant obstructive lung disease
boolean
C0600260 (UMLS CUI [1])
Thromboembolism | Pulmonary Embolism Probable
Item
evidence of thromboembolic disease (probable pulmonary embolism) within 3 years before screening
boolean
C0040038 (UMLS CUI [1])
C0034065 (UMLS CUI [2,1])
C0033204 (UMLS CUI [2,2])
Event Cerebrovascular
Item
cerebrovascular events within 3 months before screening
boolean
C0441471 (UMLS CUI [1,1])
C1880018 (UMLS CUI [1,2])
Atrial septostomy
Item
atrial septostomy within the 6 months before screening
boolean
C0397233 (UMLS CUI [1])
Cardiac Arrhythmia Severe | Coronary heart disease Severe | Angina, Unstable | Myocardial Infarction | Valvular defects Congenital | Valvular defects Acquired | Cardiomyopathy Independent of Pulmonary arterial hypertension
Item
severe arrhythmia, or severe coronary heart disease or unstable angina, or myocardial infarction within 6 months before screening, or congenital or acquired valvular defects with clinically relevant myocardial function disorders unrelated to pah
boolean
C0003811 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0010068 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0002965 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
C2748945 (UMLS CUI [5,1])
C1744681 (UMLS CUI [5,2])
C2748945 (UMLS CUI [6,1])
C0439661 (UMLS CUI [6,2])
C0878544 (UMLS CUI [7,1])
C0332291 (UMLS CUI [7,2])
C2973725 (UMLS CUI [7,3])
Systolic Pressure | Hypertensive disease Uncontrolled | Diastolic blood pressure
Item
systolic blood pressure < 85 mm hg, or uncontrolled systemic hypertension (systolic bp > 160 mmhg or diastolic bp > 100 mmhg)
boolean
C0871470 (UMLS CUI [1])
C0020538 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0428883 (UMLS CUI [3])
Hepatic impairment Child-Pugh Classification | Chronic Kidney Insufficiency | Creatinine measurement, serum | Requirement Dialysis
Item
hepatic impairment (child pugh b, c) or chronic renal insufficiency (creatinine > 2.5 mg/dl) and /or requirement of dialysis
boolean
C0948807 (UMLS CUI [1,1])
C2347612 (UMLS CUI [1,2])
C0403447 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C1514873 (UMLS CUI [4,1])
C0011946 (UMLS CUI [4,2])
Blood Coagulation Disorders | High risk of Hemorrhage | Ulcer | Trauma
Item
clinically relevant bleedings disorders or conditions with increased risk for hemorrhages (active ulcers, trauma etc.)
boolean
C0005779 (UMLS CUI [1])
C0332167 (UMLS CUI [2,1])
C0019080 (UMLS CUI [2,2])
C0041582 (UMLS CUI [3])
C3714660 (UMLS CUI [4])
Pharmacotherapy Pulmonary arterial hypertension Specific | Pharmacotherapy Additional | Medication dose changed | Endothelin receptor antagonist | Phosphodiesterase 5 inhibitor | Therapeutic procedure Additional Pulmonary arterial hypertension | Calcium Channel Blockers | Nitrates | Digitalis preparation | Diuretics | Prostaglandins
Item
addition or dose change of pah specific drug treatments such as era or pde5 inhibitors within 3 months before screening, or addition or dose change of non-specific treatments for pah such as calcium channel blockers, nitrates, digitalis, diuretics within 4 weeks before screening, or any kind of prostanoid other than those mentioned in inclusion criteria within less than 5 half-lives before treatment
boolean
C0013216 (UMLS CUI [1,1])
C2973725 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C0013216 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
C1608430 (UMLS CUI [3])
C1134681 (UMLS CUI [4])
C1318700 (UMLS CUI [5])
C0087111 (UMLS CUI [6,1])
C1524062 (UMLS CUI [6,2])
C2973725 (UMLS CUI [6,3])
C0006684 (UMLS CUI [7])
C0028125 (UMLS CUI [8])
C0304520 (UMLS CUI [9])
C0012798 (UMLS CUI [10])
C0033554 (UMLS CUI [11])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video